# Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

> **NCT00148902** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 52 (actual)

## Conditions studied

- Neoplasms, Breast

## Interventions

- **DRUG:** lapatinib
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00148902
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04-28
- **Primary completion:** 2006-01-21
- **Final completion:** 2006-01-21
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148902, "Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00148902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*